Literature DB >> 33663526

The inappropriateness of brain MRI prescriptions: a study from Iran.

Zahra Kavosi1, Abouzar Sadeghi1, Farhad Lotfi1, Hedayat Salari2, Mohsen Bayati3.   

Abstract

BACKGROUND: Inappropriate prescriptions can lead to adverse consequences for patients. It also imposes excessive cost on the patients, payers and health systems. The current study aimed at estimating the rate of inappropriate brain Magnetic Resonance Imaging (MRI) prescriptions and their financial burden in Iran.
METHODS: Using systematic stratified sampling method, this cross-sectional study recruited 385 participants from three public teaching hospitals in Shiraz, Iran. Demographic information, questions related to brain MRI prescription and its indications checklist were collected using study-specific data collection tools. The completed indications checklist was compared to the appropriateness status table of indications and scenarios to detect the percent of the appropriateness of prescriptions.
RESULTS: About 21 percentage of total brain MRI prescriptions are inappropriate. Previous treatment, number of referrals to physician, having other diagnostic tests and the applicant of MRI (P < 0.01) had significant relationships with prescription appropriateness. The estimated financial burden of inappropriate brain MRIs in Shiraz teaching hospitals was 99,988 US dollar in 2017.
CONCLUSIONS: More than one-fifth of brains MRIs were inappropriate (i.e. prescriptions without medical indications). It caused 99,988 United States Dollar (USD) financial burden which is 17 times that of Iran's Gross Domestic Product (GDP) per capita. To better allocate resources for the provision of MRI services to health system, rationing policies for controlling moral hazard and reducing provider induced demand can be helpful.

Entities:  

Keywords:  Health Expenditures; Magnetic Resonance Imaging; Medical Overuse; Neurology; Prescriptions; Unnecessary Procedures

Year:  2021        PMID: 33663526      PMCID: PMC7934493          DOI: 10.1186/s12962-021-00268-6

Source DB:  PubMed          Journal:  Cost Eff Resour Alloc        ISSN: 1478-7547


  22 in total

1.  Technology as a 'major driver' of health care costs: a cointegration analysis of the Newhouse conjecture.

Authors:  Albert A Okunad; Vasudeva N R Murthy
Journal:  J Health Econ       Date:  2002-01       Impact factor: 3.883

Review 2.  Neurodegenerative disorders and ischemic brain diseases.

Authors:  M P Mattson; W Duan; W A Pedersen; C Culmsee
Journal:  Apoptosis       Date:  2001 Feb-Apr       Impact factor: 4.677

3.  The global burden of neurological disorders.

Authors:  William M Carroll
Journal:  Lancet Neurol       Date:  2019-03-14       Impact factor: 44.182

Review 4.  PET/MRI for neurologic applications.

Authors:  Ciprian Catana; Alexander Drzezga; Wolf-Dieter Heiss; Bruce R Rosen
Journal:  J Nucl Med       Date:  2012-11-09       Impact factor: 10.057

5.  Defensive Medicine: Evidence from Military Immunity.

Authors:  Michael Frakes; Jonathan Gruber
Journal:  Am Econ J Econ Policy       Date:  2019-08

6.  Determining the appropriateness of requests for outpatient magnetic resonance imaging of the hip

Authors:  Alexander Manta; Jennie O’Grady; Robert Bleakney; John Theodoropoulos
Journal:  Can J Surg       Date:  2019-08-01       Impact factor: 2.089

7.  How do physicians respond to patient's requests for costly, unindicated services?

Authors:  T H Gallagher; B Lo; M Chesney; K Christensen
Journal:  J Gen Intern Med       Date:  1997-11       Impact factor: 5.128

8.  Analysis of appropriateness of outpatient CT and MRI referred from primary care clinics at an academic medical center: how critical is the need for improved decision support?

Authors:  Bruce E Lehnert; Robert L Bree
Journal:  J Am Coll Radiol       Date:  2010-03       Impact factor: 5.532

9.  Survey of inappropriate use of magnetic resonance imaging.

Authors:  Heljä Oikarinen; Ari Karttunen; Eija Pääkkö; Osmo Tervonen
Journal:  Insights Imaging       Date:  2013-08-15

10.  Trends in age-related disease burden and healthcare utilization.

Authors:  Vincenzo Atella; Andrea Piano Mortari; Joanna Kopinska; Federico Belotti; Francesco Lapi; Claudio Cricelli; Luigi Fontana
Journal:  Aging Cell       Date:  2018-11-29       Impact factor: 9.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.